Boston Scientific (BSX) Profit After Tax Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.46% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.66% |
| Mar 31, 2026 | 62.16% |
| Dec 31, 2025 | 68.52% |
| Sep 30, 2025 | 58.95% |
| Jun 30, 2025 | 45.14% |
| Mar 31, 2025 | 82.81% |
| Dec 31, 2024 | 80.86% |
| Sep 30, 2024 | 3.76% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 13.07% |
| Dec 31, 2023 | 33.89% |
| Sep 30, 2023 | 73.82% |
| Jun 30, 2023 | 56.55% |
| Mar 31, 2023 | 205.62% |
| Dec 31, 2022 | -67.28% |
| Sep 30, 2022 | 14.27% |
| Jun 30, 2022 | 19.07% |
| Mar 31, 2022 | -36.22% |
| Dec 31, 2021 | -37.33% |
| Sep 30, 2021 | -1.01% |